{"id":"https://openalex.org/W4392722650","doi":"https://doi.org/10.1158/2326-6066.c.6548309","title":"Data from Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment","display_name":"Data from Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4392722650","doi":"https://doi.org/10.1158/2326-6066.c.6548309"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.c.6548309","doi":"https://doi.org/10.1158/2326-6066.c.6548309","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6548309","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.c.6548309","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052140429","display_name":"Laura Evgin","orcid":"https://orcid.org/0000-0002-0913-5038","observed_orcids":["https://orcid.org/0000-0002-0913-5038"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Evgin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022285180","display_name":"Amanda L. Huff","orcid":"https://orcid.org/0000-0002-8423-8985","observed_orcids":["https://orcid.org/0000-0002-8423-8985"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda L. Huff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002555051","display_name":"Timothy J. Kottke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy Kottke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jill Thompson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jill Thompson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043724824","display_name":"Amy M. Molan","orcid":"https://orcid.org/0000-0001-8278-829X","observed_orcids":["https://orcid.org/0000-0001-8278-829X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy M. Molan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071498156","display_name":"Christopher B. Driscoll","orcid":"https://orcid.org/0000-0002-8629-1798","observed_orcids":["https://orcid.org/0000-0002-8629-1798"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher B. Driscoll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080818018","display_name":"Matthew J. Schuelke","orcid":"https://orcid.org/0000-0001-5755-1725","observed_orcids":["https://orcid.org/0000-0001-5755-1725"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Schuelke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067715117","display_name":"Kevin G. Shim","orcid":"https://orcid.org/0000-0002-3448-9452","observed_orcids":["https://orcid.org/0000-0002-3448-9452"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin G. Shim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3448-9452","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078258328","display_name":"Phonphimon Wongthida","orcid":"https://orcid.org/0009-0004-1250-8159","observed_orcids":["https://orcid.org/0009-0004-1250-8159"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Phonphimon Wongthida","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064745768","display_name":"Elizabeth J. Ilett","orcid":"https://orcid.org/0000-0002-9875-0322","observed_orcids":["https://orcid.org/0000-0002-9875-0322"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth J. Ilett","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9875-0322","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070612773","display_name":"Karen Kaluza Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Kaluza Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035901749","display_name":"Reuben S. Harris","orcid":"https://orcid.org/0000-0002-9034-9112","observed_orcids":["https://orcid.org/0000-0002-9034-9112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reuben S. Harris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078521568","display_name":"Matt C. Coffey","orcid":"https://orcid.org/0000-0002-7211-829X","observed_orcids":["https://orcid.org/0000-0002-7211-829X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matt Coffey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082704917","display_name":"Jos\u00e9 S. Pulido","orcid":"https://orcid.org/0000-0003-4804-8962","observed_orcids":["https://orcid.org/0000-0003-4804-8962","https://orcid.org/0000-0003-2009-3163"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jose S. Pulido","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067211956","display_name":"Hardev Pandha","orcid":"https://orcid.org/0000-0002-9420-7701","observed_orcids":["https://orcid.org/0000-0002-9420-7701"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hardev Pandha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086212361","display_name":"Peter John Selby","orcid":"https://orcid.org/0000-0002-3782-069X","observed_orcids":["https://orcid.org/0000-0002-3782-069X","https://orcid.org/0000-0001-5401-2996","https://orcid.org/0000-0001-9465-9268"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. Selby","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072284989","display_name":"Kevin Joseph Harrington","orcid":"https://orcid.org/0000-0002-6014-348X","observed_orcids":["https://orcid.org/0000-0002-6014-348X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin J. Harrington","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069116024","display_name":"Alan A. Melcher","orcid":"https://orcid.org/0000-0002-2042-3380","observed_orcids":["https://orcid.org/0000-0002-2042-3380"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Melcher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5070554485","display_name":"Richard G. Vile","orcid":"https://orcid.org/0000-0003-2192-9372","observed_orcids":["https://orcid.org/0000-0003-2192-9372"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard G. Vile","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5015000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5015000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.4154999852180481,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.03880000114440918,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/t-cell-immunotherapy","display_name":"T cell therapy","score":0.75},{"id":"https://openalex.org/keywords/tumor-escape","display_name":"tumor escape","score":0.578000009059906},{"id":"https://openalex.org/keywords/apobec3","display_name":"APOBEC3","score":0.6970000267028809},{"id":"https://openalex.org/keywords/c-to-t-mutations","display_name":"C>T mutations","score":0.6520000100135803},{"id":"https://openalex.org/keywords/oncolytic-virotherapy","display_name":"oncolytic virotherapy","score":0.8519999980926514},{"id":"https://openalex.org/keywords/suicide-gene-therapy","display_name":"suicide gene therapy","score":1.0},{"id":"https://openalex.org/keywords/t-cell-mediated-killing","display_name":"T cell-mediated killing","score":0.5180000066757202},{"id":"https://openalex.org/keywords/effector-to-target-ratio","display_name":"effector-to-target ratio","score":0.9580000042915344},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.640999972820282},{"id":"https://openalex.org/keywords/protein-kinase-c","display_name":"protein kinase C","score":0.9879999756813049},{"id":"https://openalex.org/keywords/antitumor-t-cells","display_name":"antitumor T cells","score":0.6489999890327454},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.5370000004768372},{"id":"https://openalex.org/keywords/shrna","display_name":"shRNA","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.7302148938179016},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.5354295969009399},{"id":"https://openalex.org/C198352243","wikidata":"https://www.wikidata.org/wiki/Q37105","display_name":"Line (geometry)","level":2,"score":0.4493756592273712},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4310971796512604},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3795306384563446},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.30510175228118896},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1499353051185608},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.062006086111068726},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.c.6548309","doi":"https://doi.org/10.1158/2326-6066.c.6548309","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6548309","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.c.6548309","doi":"https://doi.org/10.1158/2326-6066.c.6548309","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6548309","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2928326859","https://openalex.org/W2562896508","https://openalex.org/W3128091173","https://openalex.org/W2799741346","https://openalex.org/W162640785","https://openalex.org/W2914748839","https://openalex.org/W4383265707","https://openalex.org/W4362630039","https://openalex.org/W4385424690","https://openalex.org/W4394582083"],"abstract_inverted_index":{"Abstract":[0],"Antitumor":[1],"T-cell":[2,148,183],"responses":[3,184],"raised":[4],"by":[5],"first-line":[6,200],"therapies":[7],"such":[8],"as":[9,210,212],"chemotherapy,":[10],"radiation,":[11],"tumor":[12,42,63,72,131,156,186,194,222],"cell":[13,64],"vaccines,":[14],"and":[15,25,68,110,116,164,171],"viroimmunotherapy":[16],"tend":[17],"to":[18,74,98,140,190,196,207],"be":[19,208],"weak,":[20],"both":[21,168],"quantitatively":[22],"(low":[23,27],"frequency)":[24],"qualitatively":[26],"affinity).":[28],"We":[29,202],"show":[30],"here":[31],"that":[32,35,102,177,204],"T":[33,54,99],"cells":[34,43,55,73,157,195],"recognize":[36],"tumor-associated":[37],"antigens":[38,187],"can":[39],"directly":[40],"kill":[41,220],"if":[44,216],"used":[45],"at":[46,58],"high":[47],"effector-to-target":[48],"ratios.":[49],"However,":[50],"when":[51],"these":[52],"tumor-reactive":[53],"were":[56],"present":[57],"suboptimal":[59],"ratios,":[60],"direct":[61],"T-cell\u2013mediated":[62,89],"killing":[65],"was":[66,86,94,111],"reduced":[67,128],"the":[69,144,191,221],"ability":[70,192],"of":[71,105,125,130,146,152,193],"evolve":[75,197],"away":[76,198],"from":[77,133,160,199],"a":[78,114],"coapplied":[79],"therapy":[80,139,163,167],"(oncolytic":[81],"or":[82,136,180],"suicide":[83,137,161],"gene":[84,138,162],"therapy)":[85],"promoted.":[87],"This":[88],"increase":[90],"in":[91,143,155,169,172],"therapeutic":[92],"resistance":[93],"associated":[95],"with":[96],"C":[97],"transition":[100],"mutations":[101],"are":[103],"characteristic":[104],"APOBEC3":[106,127],"cytosine":[107],"deaminase":[108],"activity":[109],"induced":[112],"through":[113],"TNF\u03b1":[115],"protein":[117],"kinase":[118],"C\u2013dependent":[119],"pathway.":[120],"Short":[121],"hairpin":[122],"RNA":[123],"inhibition":[124],"endogenous":[126],"rates":[129],"escape":[132,159],"oncolytic":[134,165],"virus":[135,166],"those":[141],"seen":[142],"absence":[145],"antitumor":[147],"coculture.":[149],"Conversely,":[150],"overexpression":[151],"human":[153],"APOBEC3B":[154],"enhanced":[158],"vitro":[170],"vivo.":[173],"Our":[174],"data":[175],"suggest":[176],"weak":[178],"affinity":[179],"low":[181],"frequency":[182],"against":[185],"may":[188],"contribute":[189],"therapies.":[201],"conclude":[203],"immunotherapies":[205],"need":[206],"optimized":[209],"early":[211],"possible":[213],"so":[214],"that,":[215],"they":[217,224],"do":[218,225],"not":[219,226],"completely,":[223],"promote":[227],"treatment":[228],"resistance.":[229]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2024-03-13T00:00:00"}